Medication helps protect insulin production in type 1 diabetes
A drug approved to treat high blood pressure, called verapamil, protected insulin-producing cells in the pancreas in people with type 1 diabetes. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - March 22, 2022 Category: Consumer Health News Source Type: news

Blood pressure medication shows benefits treating Type 1 diabetes
Use of the drug verapamil to treat Type 1 diabetes continues to show benefits lasting at least two years, researchers report in the journal Nature Communications. Patients taking the oral blood pressure medication not only required less daily insulin two years after first diagnosis of the disease, but also showed evidence of surprising immunomodulatory benefits. (Source: World Pharma News)
Source: World Pharma News - March 3, 2022 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Armas Pharmaceuticals Adds Four Generic Injectables As First Launches of 2020
MANALAPAN, N.J., Jan. 20, 2020 -- (Healthcare Sales & Marketing Network) -- Armas Pharmaceuticals Inc. (Armas), has begun the new year with launches of four generic injectables: Caffeine Citrate, Docetaxel, Gemcitabine and Verapamil HCI. These products ar... Biopharmaceuticals, Generics, Product Launch Armas Pharmaceuticals, CAFCIT, Taxotere, Gemzar, Verapamil (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 20, 2020 Category: Pharmaceuticals Source Type: news

Verapamil and Cluster Headache: Still a Mystery Verapamil and Cluster Headache: Still a Mystery
Verapamil has been used for the prophylaxis of cluster headache for decades--but we still don ' t know why it works.Headache (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 18, 2019 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Effect of CYP3A4 inhibitors verapamil and itraconazole on the pharmacokinetics of AZD7986, an oral DPP1 inhibitor
Conference abstracts (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - October 13, 2019 Category: Respiratory Medicine Authors: MeganB Source Type: news

verapamil (Calan, Verelan, Verelan PM [Discontinued: Isoptin, Isoptin SR, Covera-HS])
Title: verapamil (Calan, Verelan, Verelan PM [Discontinued: Isoptin, Isoptin SR, Covera-HS])Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 8/2/2019 12:00:00 AM (Source: MedicineNet Cholesterol General)
Source: MedicineNet Cholesterol General - August 2, 2019 Category: Cardiology Source Type: news

Verapamil HCl Extended-Release Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - February 22, 2019 Category: Drugs & Pharmacology Source Type: news

Verapamil Hydrochloride (Verapamil Hydrochloride Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 30, 2018 Category: Drugs & Pharmacology Source Type: news

UAB researchers make big discovery on diabetes research
Researchers at the UAB ’s comprehensive Diabetes Center have discovered a safe and effective therapy to reduce insulin requirements and hypoglycemic episodes in adult subjects with recent onset Type 1 diabetes by promoting the patient’s own beta cell function and insulin production – the first such discovery to targ et diabetes in this way.  The findings reveal that regular oral application of verapamil, a common blood pressure medication, also enabled patients to produce higher levels of their… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 16, 2018 Category: Biotechnology Authors: Tyler Patchen Source Type: news

UAB researchers make big discovery on diabetes research
Researchers at the UAB ’s comprehensive Diabetes Center have discovered a safe and effective therapy to reduce insulin requirements and hypoglycemic episodes in adult subjects with recent onset Type 1 diabetes by promoting the patient’s own beta cell function and insulin production – the first such discovery to targ et diabetes in this way.  The findings reveal that regular oral application of verapamil, a common blood pressure medication, also enabled patients to produce higher levels of their… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 16, 2018 Category: American Health Authors: Tyler Patchen Source Type: news

Verapamil Success for T1D; Bariatric Surgery Wait; Self-Monitoring Without Insulin?
(MedPage Today) -- News and commentary from the endocrinology world (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 13, 2018 Category: Cardiology Source Type: news

Blood pressure medication effectively used to treat type 1 diabetes
Verapamil, a long-time blood pressure medication, was effective in treating recent onset type 1 diabetes, according to a Phase 2 human trial of adults. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 10, 2018 Category: Consumer Health News Source Type: news

Verapamil May Improve Beta-Cell Function in Type 1 Diabetes Verapamil May Improve Beta-Cell Function in Type 1 Diabetes
Old blood pressure drug may find a new purpose.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 10, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Verapamil effective to treat type-1 diabetes
According to results of a human clinical trial, published inNature Medicine, verapamil is a safe and effective treatment option to treat recent onset type-1 diabetes.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - July 10, 2018 Category: Endocrinology Source Type: news

Human clinical trial reveals verapamil as an effective type 1 diabetes therapy
Researchers at the University of Alabama at Birmingham Comprehensive Diabetes Center have discovered a safe and effective novel therapy to reduce insulin requirements and hypoglycemic episodes in adult subjects with recent onset Type 1 diabetes by promoting the patient's own beta cell function and insulin production - the first such discovery to target diabetes in this manner. (Source: World Pharma News)
Source: World Pharma News - July 9, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news